Barakat K - Search Results

1

Vaccine adjuvants--understanding molecular mechanisms to improve vaccines.

Egli A, Santer D, Barakat K, Zand M, Levin A, Vollmer M, Weisser M, Khanna N, Kumar D, Tyrrell L, Houghton M, Battegay M, O'Shea D. Egli A, et al. Among authors: barakat k. Swiss Med Wkly. 2014 May 20;144:w13940. doi: 10.4414/smw.2014.13940. eCollection 2014. Swiss Med Wkly. 2014. PMID: 24844935 Free article. Review.

2

Structural analysis of hERG channel blockers and the implications for drug design.

AlRawashdeh S, Chandrasekaran S, Barakat KH. AlRawashdeh S, et al. J Mol Graph Model. 2023 May;120:108405. doi: 10.1016/j.jmgm.2023.108405. Epub 2023 Jan 11. J Mol Graph Model. 2023. PMID: 36680816

3

The Anticancer Potential of Psidium guajava (Guava) Extracts.

Lok B, Babu D, Tabana Y, Dahham SS, Adam MAA, Barakat K, Sandai D. Lok B, et al. Among authors: barakat k. Life (Basel). 2023 Jan 28;13(2):346. doi: 10.3390/life13020346. Life (Basel). 2023. PMID: 36836712 Free PMC article. Review.

4

A computational model for overcoming drug resistance using selective dual-inhibitors for aurora kinase A and its T217D variant.

Barakat KH, Huzil JT, Jordan KE, Evangelinos C, Houghton M, Tuszynski J. Barakat KH, et al. Mol Pharm. 2013 Dec 2;10(12):4572-89. doi: 10.1021/mp4003893. Epub 2013 Nov 5. Mol Pharm. 2013. PMID: 24094068

5

Detailed computational study of the active site of the hepatitis C viral RNA polymerase to aid novel drug design.

Barakat KH, Law J, Prunotto A, Magee WC, Evans DH, Tyrrell DL, Tuszynski J, Houghton M. Barakat KH, et al. J Chem Inf Model. 2013 Nov 25;53(11):3031-43. doi: 10.1021/ci4003969. Epub 2013 Oct 24. J Chem Inf Model. 2013. PMID: 24116674

6

Immunomodulatory Function of Interleukin 28B during primary infection with cytomegalovirus.

Egli A, Levin A, Santer DM, Joyce M, O'Shea D, Thomas BS, Lisboa LF, Barakat K, Bhat R, Fischer KP, Houghton M, Tyrrell DL, Kumar D, Humar A. Egli A, et al. Among authors: barakat k. J Infect Dis. 2014 Sep 1;210(5):717-27. doi: 10.1093/infdis/jiu144. Epub 2014 Mar 11. J Infect Dis. 2014. PMID: 24620020

7

A Refined Model of the HCV NS5A protein bound to daclatasvir explains drug-resistant mutations and activity against divergent genotypes.

Barakat KH, Anwar-Mohamed A, Tuszynski JA, Robins MJ, Tyrrell DL, Houghton M. Barakat KH, et al. J Chem Inf Model. 2015 Feb 23;55(2):362-73. doi: 10.1021/ci400631n. Epub 2014 Apr 14. J Chem Inf Model. 2015. PMID: 24730573

8

A human ether-á-go-go-related (hERG) ion channel atomistic model generated by long supercomputer molecular dynamics simulations and its use in predicting drug cardiotoxicity.

Anwar-Mohamed A, Barakat KH, Bhat R, Noskov SY, Tyrrell DL, Tuszynski JA, Houghton M. Anwar-Mohamed A, et al. Toxicol Lett. 2014 Nov 4;230(3):382-92. doi: 10.1016/j.toxlet.2014.08.007. Epub 2014 Aug 13. Toxicol Lett. 2014. PMID: 25127758

9

IL-28B is a key regulator of B- and T-cell vaccine responses against influenza.

Egli A, Santer DM, O'Shea D, Barakat K, Syedbasha M, Vollmer M, Baluch A, Bhat R, Groenendyk J, Joyce MA, Lisboa LF, Thomas BS, Battegay M, Khanna N, Mueller T, Tyrrell DL, Houghton M, Humar A, Kumar D. Egli A, et al. Among authors: barakat k. PLoS Pathog. 2014 Dec 11;10(12):e1004556. doi: 10.1371/journal.ppat.1004556. eCollection 2014 Dec. PLoS Pathog. 2014. PMID: 25503988 Free PMC article.

10

Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA.

Ahmed M, Wang F, Levin A, Le C, Eltayebi Y, Houghton M, Tyrrell L, Barakat K. Ahmed M, et al. Among authors: barakat k. Drug Discov Today. 2015 May;20(5):548-61. doi: 10.1016/j.drudis.2015.01.008. Epub 2015 Jan 24. Drug Discov Today. 2015. PMID: 25622780 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

146 results

Search Page